Go Ad-Free
    My Alerts
    Moneycontrol
    Moneycontrol PRO
    HomeNewsBusinessBuy Glenmark Pharma, Ajanta Pharma, Cipla: Ashwani Gujral

    Buy Glenmark Pharma, Ajanta Pharma, Cipla: Ashwani Gujral

    Ashwani Gujral of ashwanigujral.com recommends buying Glenmark Pharma, Ajanta Pharma and Cipla.

    September 21, 2017 / 14:50 IST

    Ashwani Gujral of ashwanigujral.com told CNBC-TV18, "I think there is only one game in town today which is pharmaceutical. So, Glenmark Pharma is a buy with a stop loss of Rs 615 and target of Rs 670."

    "Ajanta Pharma is a buy with a stop loss of Rs 1,220 and target of Rs 1,265. Cipla is a buy with a stop loss of Rs 580 and target of Rs 615," he added.

    first published: Sep 21, 2017 02:47 pm

    Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

    Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347